The Patent Finder

Neurotech Pharmaceuticals Co., Ltd.

Also on record
Records under this name other than the patents Neurotech Pharmaceuticals Co., Ltd. holds now: patents now held by others, patents whose terms have ended, and its applications, pending or abandoned. None of them is counted in the 2 patents it holds.

Back to Neurotech Pharmaceuticals Co., Ltd.

PatentTitleStatus Expires Confidence
US 8,455,470Pharmaceutical composition for treating or preventing degenerative and inflammatory diseases
Formerly held
In force
 · From the USPTO record
In forceFrom the USPTO record
US 7,608,585Compositions for inhibition of necrosis induced by a neurotrophin
Formerly held
Term ended
Term ended Feb 8, 2025 · From the USPTO record
Term endedTerm ended Feb 8, 2025From the USPTO record
US 7,371,896Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Term ended
Term ended Aug 1, 2023 · From the USPTO record
Term endedTerm ended Aug 1, 2023From the USPTO record
US 6,927,303Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Term ended
Term ended Jun 19, 2023 · From the USPTO record
Term endedTerm ended Jun 19, 2023From the USPTO record
US 7,189,878Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Term ended
Term ended Jun 19, 2023 · From the USPTO record
Term endedTerm ended Jun 19, 2023From the USPTO record
US 7,319,160Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Term ended
Ended no later than Jun 19, 2023 · From the USPTO record
Term endedEnded no later than Jun 19, 2023From the USPTO record
US 7,511,074Tetrafluorobenzyl derivatives and pharmaceutical composition for preventing and treating acute and chronic neurodegenerative diseases in central nervous system containing the same
Term ended
Term ended Jun 19, 2023 · From the USPTO record
Term endedTerm ended Jun 19, 2023From the USPTO record
US 7,750,045Compounds, compositions and methods for preventing neurodegeneration in acute and chronic injuries in the central nervous system
Term ended
Term ended Apr 9, 2023 · From the USPTO record
Term endedTerm ended Apr 9, 2023From the USPTO record
US 7,422,874Expression vector for animal cell
Formerly held
Term ended
Term ended Dec 21, 2022 · From the USPTO record
Term endedTerm ended Dec 21, 2022From the USPTO record
US 7,259,010Expression vector for animal cell containing nuclear matrix attachment region of interferon beta
Formerly held
Term ended
Term ended Jul 17, 2022 · From the USPTO record
Term endedTerm ended Jul 17, 2022From the USPTO record
10 of 14 patents shown.
Pro members see all 14.
Pro members: see all 14 patents
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 18, 2026 · includes USPTO assignment data published Nov 17, 2026, status data published Nov 18, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited